|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/14 | |
| A61K 31/165 | |||
| A61K 31/191 |
| (11) | Number of the document | 1755388 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05754106.2 |
| Date of filing the European patent application | 2005-05-27 | |
| (97) | Date of publication of the European application | 2007-02-28 |
| (45) | Date of publication and mention of the grant of the patent | 2010-10-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/018636 |
| Date | 2005-05-27 |
| (87) | Number | WO 2005/117585 |
| Date | 2005-12-15 |
| (30) | Number | Date | Country code |
| 575247 P | 2004-05-28 | US |
| (72) |
PETERSON, Matthew, US
OLIVEIRA, Mark, US
|
| (73) |
Transform Pharmaceuticals, Inc.,
29 Hartwell Avenue, Lexington, MA 02421,
US
|
| (54) | MIXED CO-CRYSTALS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME |
| MIXED CO-CRYSTALS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME |